Clinical Trial

New Treatment for Nocturnal Enuresis in Children

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated July 12, 2024 (before its estimated September 2024 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to evaluate the role of sulbutiamine in treatment of monosymptomatic nocturnal enuresis in children by using it alone or as a combination therapy with tricyclic antidepressants (imipramine+sulbutiamine).
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-02
Trial Details
NCT Number NCT06497647
Lead Sponsor Sohag University
Conditions Nocturnal Enuresis in Children
Enrollment 450 participants
Start Date 2024-03-01
Primary Completion 2024-09 (estimated)
Study Completion 2024-11 (estimated)
Updated on ClinicalTrials.gov 2024-07-12